Print this page    •   Back to Web version of article

Opinion & Commentary
"This Is a Dynamic, Productive Time in HIV Prevention Research"

December 24, 2009

In a Washington Post letter to the editor, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, and Rafi Ahmed, science committee chairman of the Global HIV Vaccine Enterprise, challenge a recent Washington Post editorial that questioned the scientific progress being made in the search for an HIV vaccine and microbicide. "The search for a safe and effective method to prevent HIV infection and AIDS is a long journey in which we should expect both success and failure," the authors write, before highlighting the lessons learned from the recent microbicide gel study and AIDS vaccine trial in Thailand. "Contrary to the impression given by the editorial, this is a dynamic and productive time in HIV prevention research," the authors conclude (12/24).

Back to other news for December 2009


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art54957.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.